Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study

Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study

Bibliographic Details
Main Authors: Dong, Qian, Yang, Xiang-hong, Zhang, Yao, Jing, Wei, Zheng, Li-qiang, Liu, Yun-peng, Qu, Xiu-juan
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064278/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064278/

Similar Items